Inventor
MOSS STEVEN
GB17 patents
⚠️ This page may combine multiple inventors who share the name “MOSS STEVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL
7 patentsUS11304990B2Apr 19, 2022
Use of known compounds—intracellular infections
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL0 citations58
US11059844B2Jul 13, 2021
Immune stimulating macrolides
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL1 citations58
US11059845B2Jul 13, 2021
Immune stimulating macrolides
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL1 citations58
US11059846B2Jul 13, 2021
Immune stimulating compound
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL1 citations58
US10919927B2Feb 16, 2021
Immune stimulating macrolide
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL0 citations58
US11564969B2Jan 31, 2023
Immunorhelin compounds for intracellular infections
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL0 citations47
US11434258B2Sep 6, 2022
Compounds (immunorhelins)
ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL0 citations47
BIOTICA TECH LTD
4 patentsUS7390895B2Jun 24, 2008
Production of polyketides and other natural products
BIOTICA TECH LTD4 citations71
US7300942B2Nov 27, 2007
Production of polyketides and other natural products
BIOTICA TECH LTD8 citations71
US7645768B2Jan 12, 2010
Production of polyketides and other natural products
BIOTICA TECH LTD2 citations60
US7560252B2Jul 14, 2009
Borrelidin-producing polyketide synthase and its use
BIOTICA TECH LTD3 citations53
UNIV CALIFORNIA
2 patentsNEUROVIVE PHARMACEUTICAL AB
2 patentsUS10307389B2Jun 4, 2019
Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation
NEUROVIVE PHARMACEUTICAL AB2 citations62
US11147789B2Oct 19, 2021
Cell-permeable succinate compounds
NEUROVIVE PHARMACEUTICAL AB0 citations54